Walleye Trading’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,600
Closed -$35.5K 4686
2025
Q3
$35.5K Sell
4,600
-7,000
-60% -$49K ﹤0.01% 4039
2025
Q2
$84.8K Buy
11,600
+5,800
+100% +$46.8K ﹤0.01% 3660
2025
Q1
$55K Sell
5,800
-12,400
-68% -$155K ﹤0.01% 3585
2024
Q4
$300K Buy
18,200
+4,500
+33% +$69.9K ﹤0.01% 2981
2024
Q3
$202K Buy
+13,700
New +$214K ﹤0.01% 3054
2024
Q2
Sell
-19,500
Closed -$307K 4709
2024
Q1
$307K Buy
+19,500
New +$301K ﹤0.01% 3165
2023
Q4
Sell
-4,900
Closed -$60.3K 5356
2023
Q3
$60.3K Buy
+4,900
New +$72.9K ﹤0.01% 4162
2022
Q1
Sell
-1,700
Closed -$58K 5707
2021
Q4
$58K Buy
+1,700
New +$66.6K ﹤0.01% 4620
2021
Q3
Sell
-7,800
Closed -$352K 5534
2021
Q2
$352K Sell
7,800
-6,700
-46% -$297K ﹤0.01% 3328
2021
Q1
$699K Sell
14,500
-17,400
-55% -$906K ﹤0.01% 2279
2020
Q4
$1.72M Buy
31,900
+19,900
+166% +$899K 0.01% 1507
2020
Q3
$443K Buy
12,000
+1,000
+9% +$37.2K ﹤0.01% 2345
2020
Q2
$341K Sell
11,000
-2,900
-21% -$80.4K ﹤0.01% 2608
2020
Q1
$384K Buy
+13,900
New +$416K ﹤0.01% 2076
2019
Q4
Sell
-9,400
Closed -$180K 4473
2019
Q3
$180K Sell
9,400
-18,100
-66% -$425K ﹤0.01% 3005
2019
Q2
$603K Buy
+27,500
New +$603K 0.01% 2041

Other funds holding NEO

Walleye Trading's NEO Position: Q4 2025 in Review

Walleye Trading sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 925 shares — an estimated $7.14K sold.

Walleye Trading first reported a position in NEO in Q4 2015 and held it in 10 quarters. The position peaked at $322K in Q3 2023. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Walleye Trading reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 925 NeoGenomics shares in Q4 2025, an estimated $7.14K.
  • Walleye Trading first reported a position in NeoGenomics in Q4 2015 and held it in 10 quarters.
  • Walleye Trading's NeoGenomics position peaked at $322K in Q3 2023.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.